8.00
0.00
(0.00%)
At close: January 30 at 3:35:05 PM EST
Breakdown
TTM
8/31/2024
8/31/2023
8/31/2022
Operating Cash Flow
-537.83
-657.92
-303.20
-135.69
Investing Cash Flow
--
--
757.44
--
Financing Cash Flow
--
1,507.50
115.53
140.00
End Cash Position
1,326.21
1,496.73
647.15
77.38
Issuance of Capital Stock
--
1,555.00
115.53
--
Issuance of Debt
--
--
--
140.00
Repayment of Debt
--
-40.00
--
--
Free Cash Flow
-546.67
-657.92
-303.20
-135.69
8/31/2022 - 11/29/2023
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
VRTX.VI Vertex Pharmaceuticals Incorporated
447.90
+5.74%
DRUG.CN Bright Minds Biosciences Inc.
47.59
+6.68%
XSNX NovAccess Global Inc.
0.0003
0.00%
SBM.V Sirona Biochem Corp.
0.0500
0.00%
APS.TO Aptose Biosciences Inc.
0.2550
+2.00%
MDNA.TO Medicenna Therapeutics Corp.
1.3200
0.00%
DTC.CN Defence Therapeutics Inc.
1.0200
-9.73%
PXMD PaxMedica, Inc.
0.0310
0.00%
MDMA.CN Pharmala Biotech Holdings Inc.
0.2300
+2.22%
ONC.TO Oncolytics Biotech Inc.
1.0700
+0.94%